[ACS] From KRASG12Dto Pan-KRAS Inhibitors岸A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design

Squid Post time The day before yesterday 18:13 | Show all posts |Read mode
This post will be closed automatically in 2026-08-01 18:12
Reward10points

journalㄩJournal of Medicinal Chemistry

AuthorsㄩXiaoshen Ma; David L. Sloman; Timothy J. Henderson; D. Jonathan Bennett; Gianni Chessari; Philip J. Day; Ruchia Duggal; Emma Edelstein; Symon Gathiaka; Andrew Hoover; Steven Howard; Shuhei Kawamura; Yu Kobayakawa; Brian M. Lacey; Thomas W. Lyons; My S. Mansueto; Richard Miller; Shinji Mizuarai; Erik V. Munsell; Marc O*Reilly; Tsuyoshi Oshima; Ryan D. Otte; Anandan Palani; David C. Rees; Takeshi Sagara; Aaron Sather; Patrick Schopf; Kazuaki Shibata; Yuki Shikata; Nicolas Solban; Sriraman Venkataraman; Dan Su; Uma Swaminathan; Yingchun Ye; Alexander Stoeck; Yongxin Han

Published dateㄩ2026-4-23

DOIㄩ10.1021/acs.jmedchem.5c03662

PDF linkㄩhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c03662

Article linkㄩhttps://doi.org/10.1021/acs.jmedchem.5c03662

Article SourceㄩAmerican Chemical Society (ACS)


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Georgee Post time The day before yesterday 18:13 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list